BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2009
View Archived Issues
Anti-cathepsin S monoclonal antibody developed by Fusion Antibodies for cancer immunotherapy
Read More
VaxInnate's recombinant hemagglutinin influenza vaccines safe and immunogenic in healthy adults
Read More
AS-703026, a novel allosteric inhibitor of MEK, displays potent preclinical antitumor activity
Read More
IT-101 regimens compared in patients with refractory solid tumors
Read More
LTX-109 shows low propensity for in vitro resistance development in S. aureus isolates
Read More
Copper/AAV-based gene therapy increases survival in model of Menkes disease / News in Context
Read More
Boston Scientific launches Taxus Element paclitaxel-eluting coronary stent
Read More
Solvay signs partnership agreement with Huya Bioscience for access to Chinese molecule portfolio
Read More
Amgen describes p38alpha MAPK modulators for the treatment of inflammation
Read More
Phase II data on Lu-AA-21004 in depression presented, product advances to phase III
Read More
Millennium Pharmaceuticals claims proteasome inhibitors for cancer treatment
Read More
Long-acting octreotide improves cystoid maculopathy in some patients
Read More
Post-hoc data show no role for gemfibrozil in atrial fibrillation in coronary heart disease subjects
Read More
Effects of lutein supplementation in age-related macular degeneration evaluated in the EMPOLS study
Read More
Pixantrone trial shows minimal cardiac effects despite doxorubicin treatment
Read More
Santhera's phase III IONIA Trial in Friedreich's ataxia misses primary endpoint
Read More
Argenta Discovery extends major drug discovery collaboration with Genentech
Read More
Enobia's ENB-0040 receives FDA fast track designation
Read More
IntelGenx and Circ Pharma to commence proof-of-concept study of CRES pravastatin
Read More
Sucampo initiates pivotal Japanese phase III lubiprostone trial in idiopathic constipation
Read More
Bionomics to initiate human clinical trial of anxiety drug BNC-210 in Australia
Read More
Medtronic and Lilly sign marketing collaboration to provide education on diabetes
Read More
Merck & Co. to launch Tredaptive/Cordaptive in international markets in 2009
Read More
Mitsubishi Tanabe Pharma obtains approval in Japan for additional indication for Valixa
Read More
Novel tyrosine kinase inhibitors for cancer treatment discovered by Janssen
Read More
Lilly advances second Alzheimer's candidate into late-stage clinical testing
Read More
European Commission approves Qutenza for peripheral neuropathic pain
Read More
FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia
Read More